(Total Views: 586)
Posted On: 09/08/2020 12:48:49 AM
Post# of 148949
Priority of Alzheimer's Trial Submission
from July 30 call Dr Kelly stated:
MS and Alzheimer's are two of our first indications that we will explore within the central nervous system. We are moving forward on these indications and are preparing protocols for FDA submission.
I recall a discussion where it was mentioned Montefiore Hospital was interested in Alzheimer's as they had a significant patient population that they could enroll in a trial.
from July 30 call Dr Kelly stated:
MS and Alzheimer's are two of our first indications that we will explore within the central nervous system. We are moving forward on these indications and are preparing protocols for FDA submission.
I recall a discussion where it was mentioned Montefiore Hospital was interested in Alzheimer's as they had a significant patient population that they could enroll in a trial.
(2)
(0)Scroll down for more posts ▼
